4//SEC Filing
Ndhlovu Lishomwa C 4
Accession 0001104659-22-098630
CIK 0001175680other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 9:50 PM ET
Size
10.0 KB
Accession
0001104659-22-098630
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Ndhlovu Lishomwa C
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2022-09-06+112,500→ 112,500 totalExercise: $0.50From: 2022-09-06Exp: 2032-09-06→ Common Stock (112,500 underlying) - Award
Non-qualified stock option (right to buy)
2022-09-06+50,000→ 50,000 totalExercise: $0.50From: 2022-09-06Exp: 2032-09-06→ Common Stock (50,000 underlying) - Award
Non-qualified stock option (right to buy)
2022-09-06+247,111→ 247,111 totalExercise: $0.50Exp: 2032-09-06→ Common Stock (247,111 underlying)
Footnotes (1)
- [F1]As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.
Documents
Issuer
CytoDyn Inc.
CIK 0001175680
Entity typeother
Related Parties
1- filerCIK 0001898357
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 9:50 PM ET
- Size
- 10.0 KB